| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 08/12/2004 | US20040156847 Remedies for eosinophilic diseases |
| 08/11/2004 | EP1444335A2 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof |
| 08/11/2004 | EP1444330A1 Expansion of t cells in vitro and expanded t cell populations |
| 08/11/2004 | EP1007516B1 Dicyclanil polymorphs and hydrates and their preparation |
| 08/11/2004 | CN1520298A Pyrazolopyrimidines as therapeutic agents |
| 08/11/2004 | CN1520297A Sustained release drug delivery system contg. codrugs |
| 08/11/2004 | CN1518980A Method for preparing liquor pharmaceutics containing alendazole sulfoxide |
| 08/11/2004 | CN1518979A oral liquor pharmaceutics containing albendazole sulfoxide for animal use |
| 08/11/2004 | CN1518978A Mouth cavity spraying agent containing benzimidazole family for expelling worms |
| 08/11/2004 | CN1161369C Improved process for antiparasitic agent |
| 08/11/2004 | CN1161018C Composition for keeping away vermin |
| 08/10/2004 | US6773712 Dirofilaria immitis nucleic acid molecule hybridizes in a solution (consisting of sodium chloride, sodium citrate, water, and 0% formamide at 37 degree c., and washing in above solution), to a prefered nucleic acid sequence |
| 08/10/2004 | US6773710 Recombinant canine distemper virus vaccine against canine distemper and leishmaniasis |
| 08/05/2004 | WO2004065349A1 Medically useful 1-phenyl-2-aminomethyl naphthalenes, method for producing them, drugs containing them and use thereof |
| 08/05/2004 | WO2004010974A3 Gelatin capsule exhibiting reduced cross-linking |
| 08/05/2004 | WO2004010973A3 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage |
| 08/05/2004 | WO2003103590A3 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents |
| 08/05/2004 | WO2003048383A3 Effectors of innate immunity |
| 08/05/2004 | US20040152754 Cyclic AMP-specific phosphodiesterase inhibitors |
| 08/05/2004 | US20040152729 Using a 4-((ho-phenyl)-nh-)quinoline compound |
| 08/05/2004 | US20040152645 Antihelminthic anthraquinones and method of use thereof |
| 08/05/2004 | US20040152157 G-protein coupled receptors |
| 08/05/2004 | US20040152078 Genetic engineering |
| 08/05/2004 | DE10304374A1 Neue substituierte 2-Aminoimidazole, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament New substituted 2-Aminoimidazole, processes for their preparation, their use as a medicament or diagnostic, and they drug-containing |
| 08/04/2004 | EP1442008A1 Unsaturated 1-amino-alkylcyclohexane nmda, 5ht3 and neuronal nicotinic receptor antagonists |
| 08/04/2004 | EP1441754A1 Use of egf to inhibit pathogenic infections of the urogenital tract |
| 08/04/2004 | EP1441725A1 Benzimidazoles and analogues and their use as protein kinases inhibitors |
| 08/04/2004 | EP1441715A1 Lipoxins and aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases |
| 08/04/2004 | EP1165140B1 Adjuvant compositions for enhancing immune responses to polynucleotide-based vaccines |
| 08/04/2004 | EP1150658B1 Method for controlling liposome size |
| 08/04/2004 | EP0951299B1 Method of producing active immunity with vaccine conjugate |
| 08/04/2004 | CN1518542A Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes |
| 08/04/2004 | CN1518459A Remedies for eosinophilic diseases |
| 08/04/2004 | CN1518447A Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents |
| 08/04/2004 | CN1160371C NOTCH protein and their ligands |
| 08/04/2004 | CN1160069C Palladium-substd. bacteriochlorophll derivatives and use thereof |
| 08/03/2004 | US6770652 Multiple acting anti-angiogenic and cytotoxic compounds and methods for using the same |
| 07/29/2004 | WO2004063377A1 Drug screening method, recombinant vector, transformant and therapeutic composition for disease caused by apicomplexan parasite |
| 07/29/2004 | WO2004062673A1 Anti-protozoal compositions comprising diclazuril |
| 07/29/2004 | WO2004062645A1 Microspheres containing amphotericin b |
| 07/29/2004 | WO2004024889A3 Production of bispecific molecules using polyethylene glycol linkers |
| 07/29/2004 | WO2004019910A3 Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract |
| 07/29/2004 | WO2004010972A3 Pellicle-resistant gelatin capsule |
| 07/29/2004 | US20040147745 Novel compounds and compositions as protease inhibitors |
| 07/29/2004 | US20040147724 for diagnosis/treatment of cancer, myeloproliferative disorders, angiogenesis, obesity, osteoporosis, non-insulin dependent diabetes, lipid metabolism disorder, hypercalcemia, hypercholestrolemia; genetic engineering |
| 07/29/2004 | US20040147558 Synthesis of 3-amino-thalidomide and its enantiomers |
| 07/29/2004 | US20040147468 Immunostimulatory nucleic acid molecules |
| 07/29/2004 | US20040146542 Non-therapeutical process for deterring vermin from warm-blooded animals, whereby 2-substituted-piperidine compound is is applied topically, together with a spreading additive, to the skin, the pelt or the plumage of the warm-blooded animal |
| 07/29/2004 | DE10301650A1 New 1-phenyl-2-aminomethylnaphthalene derivatives used for treating tumors, neurodegeneration, inflammation and Chagas disease |
| 07/29/2004 | CA2512176A1 Anti-protozoal compositions comprising diclazuril |
| 07/28/2004 | EP1440166A2 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777 |
| 07/28/2004 | EP1440066A1 Pyrazolyl-substituted heterocycles and their use as phytosanitary products |
| 07/28/2004 | EP1440062A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles |
| 07/28/2004 | EP1439819A1 Formulation of an erodible, gastic retentive oral dosage form using in vitro disintegration test data |
| 07/28/2004 | EP1372659B1 Substances for use in therapy of diseases that are caused by highly proliferative cells |
| 07/28/2004 | EP0927183B1 Spirocyclic metalloprotease inhibitors |
| 07/28/2004 | CN1516739A Use of HMG fragments as anti-inflammatory agents |
| 07/28/2004 | CN1516735A Method to generate non-virulent microorganism from pathogenic ones trough permanent genetic modification of their biological membrane for vaccine production |
| 07/28/2004 | CN1516692A Novel compounds of family of 3-alkyl-(4,5-diphenyl-imidazol-1-yl) and their use as soothing agents |
| 07/28/2004 | CN1159333C Trichina antigen gene Ts 87 and use thereof |
| 07/28/2004 | CN1159302C Triazine derivatives, their production and use |
| 07/28/2004 | CN1159298C Parasiticidal compound |
| 07/28/2004 | CN1159011C 苦参碱阴道凝胶 Matrine vaginal gel |
| 07/27/2004 | US6767561 Plant extracts as antiproliferative, viricides and antiparasitic agents |
| 07/27/2004 | US6767549 Ionic polymers as anti-infective agents |
| 07/22/2004 | WO2003072135A3 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors |
| 07/22/2004 | US20040143001 Using photodynamic compound; bactericides, fungicides, viricides; killing microorganisms |
| 07/22/2004 | US20040142999 Novel compounds and compositions as cathepsin inhibitors |
| 07/22/2004 | US20040142932 treating diseases and conditions caused or exacerbated by unregulated p38 MAP Kinase activity |
| 07/22/2004 | US20040142877 Ligands of the $g(a)v$g(b)6 integrin |
| 07/21/2004 | EP1439172A1 Method of obtaining 2-(2-nitrovinyl)-furan and the use thereof as a coccidiostatic |
| 07/21/2004 | EP1438405A1 Use of a double-stranded ribonucleic acid for specifically inhibiting the expression of a given target gene |
| 07/21/2004 | EP1226137B1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 07/21/2004 | CN1514724A Parasiticides for farmed fish |
| 07/21/2004 | CN1513852A Plant extract and its application |
| 07/21/2004 | CN1513474A Animal medicine composition for preventing and treating coccidiosis |
| 07/21/2004 | CN1513464A Injection of invermection for treating ox-warble myiosis |
| 07/21/2004 | CN1158387C Chimeric gene encoding antigenic determinants of four proteins of L.INFANTUM |
| 07/21/2004 | CN1158276C Phenyl-and pyridyl-tetrahydro-pyridines having TNF inhibiting activity |
| 07/21/2004 | CN1158248C Process for preparing diclazuril as veterinary medicine for coccidiosis |
| 07/21/2004 | CN1158074C Pharmaceutical compositions of tizoxanide and nitazoxanide |
| 07/15/2004 | WO2004019911A3 Buccal, polar or non-polar spray or capsule containing drugs for treating endocrine disorders |
| 07/15/2004 | US20040138416 Comprises membrane protein for use in diagnosis prevention and treatment of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune, inflammatory, metabolic and viral disorders |
| 07/15/2004 | US20040138264 Tetrahydropyridly-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same |
| 07/15/2004 | US20040138250 Inhibitors of cruzipain and other cysteine proteases |
| 07/15/2004 | US20040138151 solvent extraction; plant extracts; chromatography |
| 07/15/2004 | US20040138149 slurrying; precipitation; for treatment of bacterial infections |
| 07/15/2004 | US20040137564 for diagnosing, treating, or preventing cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders, and viral infections;solid phase synthesis |
| 07/15/2004 | US20040137512 Malaria plasmodium antigen polypeptide se36, method of purifyng the same and vaccine and diagnostic with the use of the thus obtained antigen |
| 07/15/2004 | US20040137446 Fab I and inhibition of apicomplexan parasites |
| 07/14/2004 | EP1437339A1 Substituted benzoic acid derivatives exhibiting nf-kappa b inhibiting activity |
| 07/14/2004 | EP1436383A2 Secreted proteins |
| 07/14/2004 | EP1436272A1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 07/14/2004 | EP1436269A1 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1436255A1 Novel compounds and compositions as cathepsin inhibitors |
| 07/14/2004 | EP1436250A1 Cyanoacetyl compounds |
| 07/14/2004 | EP1436008A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 07/14/2004 | EP1435992A2 Chemokines as adjuvants of immune response |
| 07/14/2004 | EP1435985A2 Medicament containing activated antithrombin iii |
| 07/14/2004 | EP1435950A1 2'-methyl-5'-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |